Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 2
1987 1
1988 1
1989 3
1990 5
1991 2
1992 6
1993 8
1994 5
1995 9
1996 6
1997 4
1998 4
1999 5
2000 11
2001 14
2002 21
2003 18
2004 12
2005 11
2006 15
2007 20
2008 24
2009 20
2010 21
2011 13
2012 24
2013 19
2014 35
2015 34
2016 34
2017 33
2018 36
2019 34
2020 57
2021 59
2022 55
2023 37
2024 30

Text availability

Article attribute

Article type

Publication date

Search Results

640 results

Results by year

Filters applied: . Clear all
Page 1
Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I.
Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, Gieler U, Girolomoni G, Lau S, Muraro A, Czarnecka-Operacz M, Schäfer T, Schmid-Grendelmeier P, Simon D, Szalai Z, Szepietowski JC, Taïeb A, Torrelo A, Werfel T, Ring J; European Dermatology Forum (EDF), the European Academy of Dermatology and Venereology (EADV), the European Academy of Allergy and Clinical Immunology (EAACI), the European Task Force on Atopic Dermatitis (ETFAD), European Federation of Allergy and Airways Diseases Patients’ Associations (EFA), the European Society for Dermatology and Psychiatry (ESDaP), the European Society of Pediatric Dermatology (ESPD), Global Allergy and Asthma European Network (GA2LEN) and the European Union of Medical Specialists (UEMS). Wollenberg A, et al. Among authors: girolomoni g. J Eur Acad Dermatol Venereol. 2018 May;32(5):657-682. doi: 10.1111/jdv.14891. J Eur Acad Dermatol Venereol. 2018. PMID: 29676534
Psoriasis and the metabolic syndrome.
Gisondi P, Fostini AC, Fossà I, Girolomoni G, Targher G. Gisondi P, et al. Among authors: girolomoni g. Clin Dermatol. 2018 Jan-Feb;36(1):21-28. doi: 10.1016/j.clindermatol.2017.09.005. Epub 2017 Sep 8. Clin Dermatol. 2018. PMID: 29241748 Review.
A systematic review of treatments for pityriasis lichenoides.
Bellinato F, Maurelli M, Gisondi P, Girolomoni G. Bellinato F, et al. Among authors: girolomoni g. J Eur Acad Dermatol Venereol. 2019 Nov;33(11):2039-2049. doi: 10.1111/jdv.15813. Epub 2019 Aug 8. J Eur Acad Dermatol Venereol. 2019. PMID: 31318465
Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II.
Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, Gieler U, Girolomoni G, Lau S, Muraro A, Czarnecka-Operacz M, Schäfer T, Schmid-Grendelmeier P, Simon D, Szalai Z, Szepietowski JC, Taïeb A, Torrelo A, Werfel T, Ring J; European Dermatology Forum (EDF), the European Academy of Dermatology and Venereology (EADV), the European Academy of Allergy and Clinical Immunology (EAACI), the European Task Force on Atopic Dermatitis (ETFAD), European Federation of Allergy and Airways Diseases Patients’ Associations (EFA), the European Society for Dermatology and Psychiatry (ESDaP), the European Society of Pediatric Dermatology (ESPD), Global Allergy and Asthma European Network (GA2LEN) and the European Union of Medical Specialists (UEMS). Wollenberg A, et al. Among authors: girolomoni g. J Eur Acad Dermatol Venereol. 2018 Jun;32(6):850-878. doi: 10.1111/jdv.14888. J Eur Acad Dermatol Venereol. 2018. PMID: 29878606
Treat-to-Target in Atopic Dermatitis: An International Consensus on a Set of Core Decision Points for Systemic Therapies.
De Bruin-Weller M, Biedermann T, Bissonnette R, Deleuran M, Foley P, Girolomoni G, Hercogová J, Hong CH, Katoh N, Pink AE, Richard MA, Shumack S, Silvestre JF, Weidinger S. De Bruin-Weller M, et al. Among authors: girolomoni g. Acta Derm Venereol. 2021 Feb 17;101(2):adv00402. doi: 10.2340/00015555-3751. Acta Derm Venereol. 2021. PMID: 33491094 Free PMC article.
Survival, efficacy and safety of tralokinumab after 32 and 52 weeks of treatment for moderate-to-severe atopic dermatitis in adults: A multicentre real-world study.
Pezzolo E, Schena D, Gambardella A, Rossi M, Barei F, Calzavara Pinton P, Girolomoni G, Naldi L, Ferrucci SM. Pezzolo E, et al. Among authors: girolomoni g. J Eur Acad Dermatol Venereol. 2024 Jan;38(1):e11-e13. doi: 10.1111/jdv.19382. Epub 2023 Aug 1. J Eur Acad Dermatol Venereol. 2024. PMID: 37483150 No abstract available.
Nivolumab induced morphea.
Dal Bello G, Rosina P, Colato C, Girolomoni G. Dal Bello G, et al. Among authors: girolomoni g. G Ital Dermatol Venereol. 2020 Oct;155(5):701-702. doi: 10.23736/S0392-0488.18.06118-7. Epub 2018 Oct 3. G Ital Dermatol Venereol. 2020. PMID: 30295447 No abstract available.
European consensus-based (S2k) Guideline on the Management of Herpes Zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment.
Werner RN, Nikkels AF, Marinović B, Schäfer M, Czarnecka-Operacz M, Agius AM, Bata-Csörgő Z, Breuer J, Girolomoni G, Gross GE, Langan S, Lapid-Gortzak R, Lesser TH, Pleyer U, Sellner J, Verjans GM, Wutzler P, Dressler C, Erdmann R, Rosumeck S, Nast A. Werner RN, et al. Among authors: girolomoni g. J Eur Acad Dermatol Venereol. 2017 Jan;31(1):20-29. doi: 10.1111/jdv.13957. Epub 2016 Nov 2. J Eur Acad Dermatol Venereol. 2017. PMID: 27579792
640 results